A 58-year-old woman with relapsed multiple myeloma (progressed 8 months after completing VRd induction and autologous stem cell transplantation) presents with bone pain and rising M-spike. She is bortezomib-refractory. What is the drug of choice for salvage therapy in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.